Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to provide evidence that Compound Sodium Alginate Double Action
Chewable Tablets are effective in managing the symptoms of heartburn, acid regurgitation and
dyspepsia in patients with Gastroesophageal Reflux Disease (GERD).